22 December 2005
Prevalence and risk factors for HEV infection in pregnant women.
Serkan Oncu, Selcen Oncu, Pinar Okyay, Sema Ertug, Serhan SakaryaMed Sci Monit 2006; 12(1): CR36-39 :: ID: 443191
Abstract
Background: Hepatitis E is an infectious viral disease with clinical andmorphological features of acute hepatitis, clinically similar to other forms of acute viral hepatitisexcept in pregnant women, in whom the illness is particularly severe and has a high mortality rate. Thepresent study was conducted in western Turkey to investigate the prevalence and risk factors for HEVinfection in pregnant women. Material/Methods: The data for the study were acquired from health centersin urban and rural areas of Aydin province, Turkey. The study design was cross-sectional. Multistagesampling was used to select the study group. Samples were tested for anti-HEV IgG by commercial ELISAtest. Results: A total of 386 pregnant women were included in the study. Antibodies against HEV weredetected in 27 of the 386 pregnant women (7.0%). The prevalence of HEV seropositivity was significantlylower (2.5%) in women with a higher education level when compared to women with a lower education level(9.7%) (p=0.023). No significant differences were identified between seropositive and seronegative womenin terms of age, source of water supply and place of residence. Conclusions: According to our results,education seems to be the only factor affecting the prevalence of HEV infection in pregnant women. Theprevalence rate we found was similar to the results obtained in previous community-based studies conductedin western Turkey.
Keywords: Antibodies, Viral - blood, Hepatitis E - physiopathology, Hepatitis E virus, Pregnancy, Pregnancy Complications, Infectious, Questionnaires, Risk Factors, Turkey - epidemiology
Editorial
04 June 2022 : Editorial
Editorial: Acute Hepatitis of Unknown Origin in Children. Is Autoimmunity at Play?DOI: 10.12659/MSM.937371
Med Sci Monit 2022; 28:e937371
SARS-CoV-2/COVID-19
30 June 2022 : Editorial
Editorial: World Health Organization (WHO) Variants of Concern Lineages Under Monitoring (VOC-LUM) in Respo...Med Sci Monit In Press; DOI: 10.12659/MSM.937676
27 June 2022 : Clinical Research
Shoulder Injury Related to Vaccine Administration (SIRVA) in 16 Patients Following COVID-19 Vaccination Who...Med Sci Monit In Press; DOI: 10.12659/MSM.937430
04 June 2022 : Clinical Research
Screening for SARS-CoV-2 Infection in Students at the Medical University of Warsaw, Poland Between November...Med Sci Monit 2022; 28:e936962
30 May 2022 : Clinical Research
Effects of Wearing Face Masks on Exercise Capacity and Ventilatory Anaerobic Threshold in Healthy Subjects ...Med Sci Monit 2022; 28:e936069
In Press
30 Jun 2022 : Laboratory Research
Bcl-2 19-kDa Interacting Protein 3 (BNIP3)-Mediated Mitophagy Attenuates Intermittent Hypoxia-Induced Human...Med Sci Monit In Press; DOI: 10.12659/MSM.936760
30 Jun 2022 : Editorial
Editorial: World Health Organization (WHO) Variants of Concern Lineages Under Monitoring (VOC-LUM) in Respo...Med Sci Monit In Press; DOI: 10.12659/MSM.937676
30 Jun 2022 : Clinical Research
Antioxidant System and Ions Concentrations After Femoral Neck and Resurfacing Hip ArthroplastyMed Sci Monit In Press; DOI: 10.12659/MSM.936335
28 Jun 2022 : Meta-Analysis
Urodynamics in Early Diagnosis of Diabetic Bladder Dysfunction in Women: A Systematic Review and Meta-AnalysisMed Sci Monit In Press; DOI: 10.12659/MSM.937166
Most Viewed Current Articles
30 Dec 2021 : Clinical Research
Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...DOI :10.12659/MSM.935379
Med Sci Monit 2021; 27:e935379
08 Mar 2022 : Review article
A Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...DOI :10.12659/MSM.936292
Med Sci Monit 2022; 28:e936292
01 Nov 2020 : Review article
Long-Term Respiratory and Neurological Sequelae of COVID-19DOI :10.12659/MSM.928996
Med Sci Monit 2020; 26:e928996
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952